World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
95
Citations
31087
World Ranking
638
National Ranking
348

Guillermina Lozano publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Guillermina Lozano sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 290 publications — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Guillermina Lozano D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Guillermina Lozano sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 95 D-Index — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Guillermina Lozano is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research focuses primarily on biochemistry, genetics, and molecular biology, with significant work in medicine as well. Within these broad fields, the scientist's contributions target subfields such as molecular biology, oncology, cancer research, epidemiology, and pulmonary and respiratory medicine.

The main topics covered in Guillermina Lozano's research include cancer-related molecular pathways, epigenetics and DNA methylation, RNA modifications and cancer, pancreatic and hepatic oncology research, cancer genomics and diagnostics, protein degradation and inhibitors, and ubiquitin and proteasome pathways.

Frequent publication venues for their work include Cancer Research, Cancer Discovery, Proceedings of the National Academy of Sciences, Cell Death and Disease, and Science Advances.

Scientific collaborations have been a consistent part of their work. Frequent co-authors include Shunbin Xiong, Xiaoping Su, Yuan Qi, Gilda P. Chau, and Amanda R. Wasylishen.

Examples of recent papers authored or co-authored by Guillermina Lozano are:

  • Oncogenic KRAS Recruits an Expansive Transcriptional Network through Mutant p53 to Drive Pancreatic Cancer Metastasis, 2021, Cancer Discovery
  • p53 tetramerization: at the center of the dominant-negative effect of mutant p53, 2020, Genes & Development
  • p53 drives a transcriptional program that elicits a non-cell-autonomous response and alters cell state in vivo, 2020, Proceedings of the National Academy of Sciences
  • Daxx maintains endogenous retroviral silencing and restricts cellular plasticity in vivo, 2020, Science Advances
  • Mammary-specific expression of Trim24 establishes a mouse model of human metaplastic breast cancer, 2021, Nature Communications

Best Publications

  • Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53

    Roberta Montes de Oca Luna;Daniel S. Wagner;Guillermina Lozano

  • A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans.

    Gareth L. Bond;Wenwei Hu;Elisabeth E. Bond;Harlan Robins

  • Gain of Function of a p53 Hot Spot Mutation in a Mouse Model of Li-Fraumeni Syndrome

    Gene A. Lang;Tomoo Iwakuma;Young Ah Suh;Geng Liu

  • Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene

    Loretta Raycroft;Hongyun Wu;Guillermina Lozano

  • Pirh2, a p53-Induced Ubiquitin-Protein Ligase, Promotes p53 Degradation

    Roger P. Leng;Yunping Lin;Weili Ma;Hong Wu

  • Rescue of embryonic lethality in Mdm4 -null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53

    John Parant;Arturo Chavez-Reyes;Arturo Chavez-Reyes;Natalie A. Little;Wen Yan

  • NF-kappa B activation of p53. A potential mechanism for suppressing cell growth in response to stress.

    Hongyun Wu;Guillermina Lozano

  • Mutant p53 Prolongs NF-κB Activation and Promotes Chronic Inflammation and Inflammation-Associated Colorectal Cancer

    Tomer Cooks;Ioannis S. Pateras;Ohad Tarcic;Hilla Solomon

  • p53-independent functions of the p19ARF tumor suppressor

    Jason D. Weber;John R. Jeffers;Jerold E. Rehg;David H. Randle

  • CRITICAL ROLE FOR SER20 OF HUMAN P53 IN THE NEGATIVE REGULATION OF P53 BY MDM2

    Tamar Unger;Tamar Juven-Gershon;Eli Moallem;Michael Berger

  • The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss

    Tamara Terzian;Young Ah Suh;Tomoo Iwakuma;Sean M. Post

  • Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4.

    Jean-Christophe Marine;Sarah Francoz;Marion Maetens;G Wahl

  • Chromosome stability, in the absence of apoptosis, is critical for suppression of tumorigenesis in Trp53 mutant mice.

    Geng Liu;John M Parant;Gene Lang;Patty Chau

  • PML, a growth suppressor disrupted in acute promyelocytic leukemia.

    Zhao Mei Mu;Khew Voon Chin;Jin Hwang Liu;Guillermina Lozano

  • p53 mutation heterogeneity in cancer

    T. Soussi;Guillermina Lozano

  • A DNA damage-induced p53 serine 392 kinase complex contains CK2, hSpt16, and SSRP1.

    David M Keller;Xiaoya Zeng;Yun Wang;Qing Hong Zhang

  • Mutual Dependence of MDM2 and MDMX in Their Functional Inactivation of p53

    Jijie Gu;Hidehiko Kawai;Linghu Nie;Hiroyuki Kitao

  • Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatment

    E. M. Alexandrova;A. R. Yallowitz;D. Li;S. Xu

  • A Pin1/mutant p53 axis promotes aggressiveness in breast cancer.

    Javier E. Girardini;Javier E. Girardini;Marco Napoli;Marco Napoli;Silvano Piazza;Alessandra Rustighi;Alessandra Rustighi

  • Synthetic small inhibiting RNAs: Efficient tools to inactivate oncogenic mutations and restore p53 pathways

    Luis Alfonso Martinez;Irina Naguibneva;Heike Lehrmann;Arlette Vervisch

Frequent Co-Authors

Adel K. El-Naggar
Adel K. El-Naggar The University of Texas MD Anderson Cancer Center
Louise C. Strong
Louise C. Strong The University of Texas MD Anderson Cancer Center
Arnold J. Levine
Arnold J. Levine Institute for Advanced Study
Christopher I. Amos
Christopher I. Amos Baylor College of Medicine
Bin Liu
Bin Liu Australian National University
Moshe Oren
Moshe Oren Weizmann Institute of Science
Lawrence A. Donehower
Lawrence A. Donehower Baylor College of Medicine
Varda Rotter
Varda Rotter Weizmann Institute of Science
Björn Olsen
Björn Olsen Harvard University
Ralf Krahe
Ralf Krahe The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Molecular Biology in the USA can open doors to diverse career pathways, both within science and in related interdisciplinary fields. As science professionals look to advance or broaden their credentials, exploring online degree options can offer flexible, affordable routes to further education.

Some students interested in scientific research might consider branching into social sciences or historical studies. For those seeking value, the cheapest online masters in history can provide a cost-effective advanced degree with broad career potential.

Others may pursue roles in academia or specialized libraries, where expertise in information management is critical. If this interests you, explore what schools offer library science degrees, which can be completed online at affordable rates.

For those drawn to healthcare, transitioning into speech-language pathology is an excellent option. Look for asha approved slp programs, some of which are accelerated and offered online. Not from an SLP background? Research slp bridge program online pathways to help non-majors meet prerequisites efficiently.

These related online degrees offer flexible, reputable options for those with a background or interest in molecular biology to diversify their skills and advance their careers.

Best Scientists Citing Guillermina Lozano

Trending Scientists